ISSN: ISSN
1758-2008 (Print )
1758-2016 (Electronic)

Diagnosis of Cancer Research and Treatment

Welcome to the Diagnosis of Cancer Research and Treatment

Journal h-index : 32
Journal cite score : 0.55
Journal impact factor : 2.39
Average acceptance to publication time (5-7 days)
Average article processing time (30-45 days)

Editorial Board

Diagnosis of Cancer Research and Treatment (DCRT) is a peer-reviewed, open-access journal dedicated to publishing innovative research in cancer diagnosis, treatment methodologies, and emerging therapeutic strategies. The journal serves as a global platform for oncologists, researchers, and healthcare professionals to share groundbreaking discoveries in cancer screening, biomarker development, precision medicine and targeted therapies. DCRT aims to bridge the gap between laboratory research and clinical applications, contributing to advancements in cancer care and patient outcomes.

Journal Highlights

Cancer research and treatment encompass a broad scope of scientific inquiry, medical advancements, and innovative therapies aimed at diagnosing, managing, and ultimately curing cancer. The field is ever evolving, integrating new technologies and methodologies to improve early detection, precise treatment, and patient outcomes. To maintain the highest research standards, we implement a rigorous double-blind peer-review process, guaranteeing the credibility and integrity of published work. As an open-access journal, we provide unrestricted access to articles, enhancing their visibility and increasing citation impact. Additionally, our fast-track publication process ensures an efficient editorial workflow, accelerating the dissemination of significant scientific findings. With a strong global outreach, we engage an international network of researchers, scholars, and healthcare professionals, fostering collaboration and knowledge exchange across various disciplines.

Scope of the Journal

The journal publishes research covering a broad spectrum of Biomedical Sciences & Research, including but not limited to:

  • Cancer Biomarkers
  • Molecular and Genetic Diagnostics
  • Radiology and Imaging Techniques
  • Targeted Therapy and Immunotherapy
  • Surgical Oncology and Interventional Radiology
  • Chemotherapy and Radiation Therapy
  • Artificial Intelligence and Big Data in Oncology
  • Cancer Epidemiology and Prevention

h-index
Articles published in Neuropsychiatry have been cited by esteemed scholars and scientists all around the world. Neuropsychiatry has got h-index 32, which means every article in Neuropsychiatry has got 32 average citations.

Journal Metrics:

Impact Factor 2.19
Scimago Journal Rank (SJR) 25
SJR Total Cites 20
Source Normalized Impact per Paper (SNIP) 14.82
h-index (2023) 40
PubMed NLM ID: 101558757
Google Scholar h5 index: 32
Iindex Copernicus Value: 119.6

Publons

Indexing Services